(Q48359259)

English

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism

scientific article published in October 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

0 references

author name string

Schluger JH

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Ho A

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Borg L

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Porter M

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Maniar S

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Gunduz M

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Perret G

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

King A

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Kreek MJ

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

22

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

1430-1436

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Identification of two related pentapeptides from the brain with potent opiate agonist activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Alteration of ethanol self-administration by naltrexone.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Naltrexone-induced opiate receptor supersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Chronic cocaine alters brain mu opioid receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Regulation of kappa opioid receptor mRNA in the rat brain by "binge' pattern cocaine administration and correlation with preprodynorphin mRNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute "binge" cocaine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Marijuana's interaction with brain reward systems: update 1991.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

The role of CRF in the release of ACTH by opiate agonists and antagonists in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03931.X

21 January 2018

Identifiers

10.1111/J.1530-0277.1998.TB03931.X

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9802524

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48359259&oldid=2195826429"